Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
14.23
+1.05 (7.97%)
At close: Jun 6, 2025, 4:00 PM
14.59
+0.36 (2.53%)
After-hours: Jun 6, 2025, 7:59 PM EDT

Capricor Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
17.3622.2725.182.550.240.31
Upgrade
Revenue Growth (YoY)
-35.92%-11.55%886.81%941.85%-21.06%-69.13%
Upgrade
Cost of Revenue
57.7849.9736.4521.8213.578.46
Upgrade
Gross Profit
-40.42-27.7-11.27-19.27-13.33-8.15
Upgrade
Selling, General & Admin
16.8614.8712.8110.437.615.54
Upgrade
Operating Expenses
16.8614.8712.8110.437.615.54
Upgrade
Operating Income
-57.28-42.56-24.08-29.7-20.94-13.69
Upgrade
Interest & Investment Income
2.462.21.730.520.060.03
Upgrade
Other Non Operating Income (Expenses)
0.020.010.07---
Upgrade
EBT Excluding Unusual Items
-54.8-40.35-22.28-29.18-20.88-13.66
Upgrade
Gain (Loss) on Sale of Assets
-0.26-0.11-0.01-0.03-0.01-
Upgrade
Other Unusual Items
---0.190.87-
Upgrade
Pretax Income
-55.06-40.47-22.29-29.02-20.02-13.66
Upgrade
Net Income
-55.06-40.47-22.29-29.02-20.02-13.66
Upgrade
Net Income to Common
-55.06-40.47-22.29-29.02-20.02-13.66
Upgrade
Shares Outstanding (Basic)
393527252316
Upgrade
Shares Outstanding (Diluted)
393527252316
Upgrade
Shares Change (YoY)
37.04%31.52%9.06%6.34%48.28%319.55%
Upgrade
EPS (Basic)
-1.42-1.15-0.83-1.18-0.87-0.88
Upgrade
EPS (Diluted)
-1.42-1.15-0.83-1.18-0.87-0.88
Upgrade
Free Cash Flow
-47.18-41.53-27.641.56-18.01-10.6
Upgrade
Free Cash Flow Per Share
-1.22-1.18-1.030.06-0.78-0.68
Upgrade
Gross Margin
-232.78%-124.37%-44.76%---
Upgrade
Operating Margin
-329.90%-191.13%-95.63%-1163.93%-8549.86%-4412.56%
Upgrade
Profit Margin
-317.13%-181.71%-88.52%-1137.37%-8175.86%-4401.94%
Upgrade
Free Cash Flow Margin
-271.69%-186.50%-109.79%61.02%-7352.29%-3417.38%
Upgrade
EBITDA
-55.78-41.14-23.01-29.16-20.69-13.55
Upgrade
EBITDA Margin
--184.73%-91.39%---
Upgrade
D&A For EBITDA
1.51.431.070.530.250.14
Upgrade
EBIT
-57.28-42.56-24.08-29.7-20.94-13.69
Upgrade
EBIT Margin
--191.13%-95.63%---
Upgrade
Revenue as Reported
17.3622.2725.182.550.240.31
Upgrade
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q